Looking back on the discovery of α-bungarotoxin

被引:37
作者
Chang, CC [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 100, Taiwan
关键词
alpha-bungarotoxin; beta-bungarotoxin; nicotinic acetylcholine receptors autodesensitization; up- and downregulation; acetylcholine; explosive release; Wedensky inhibition; endplate potential run-down; tubocurarine; succinylcholine; neostigmine;
D O I
10.1159/000025412
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This review is a personal narration by a retiring pharmacologist from Taiwan who looks back at his discovery of alpha-bungarotoxin from the historical perspective of Taiwan during the last 50 years, with accounts of his experiences and his efforts to overcome hardship. Flow the a-toxin was isolated and characterized as an irreversible specific nicotinic acetylcholine (ACh) receptor antagonist, and how it subsequently became a useful experimental probe are presented here. The dilemma of differentiating the actions of tubocurarine and alpha-bungarotoxin is analyzed. The author also outlines findings based on work done in his laboratory using alpha-bungarotoxin as a tool on particular aspects of synaptic transmission. These include presynaptic receptor for positive feedback of transmitter release, explosive release of ACh, up- and downregulation of ACh receptors after chronic drug treatment, autodesensitization of junctional ACh receptors, differences in action between natural transmitter and exogenous agonists and that between junctional and extra-junctional ACh receptors. Some experimental pitfalls, in which biomedical scientists are frequently trapped, are raised. Finally, some anecdotes are appended from which the reader may further understand scientific life in the 20th century, including its joys and regrets.
引用
收藏
页码:368 / 375
页数:8
相关论文
共 29 条
[1]  
[Anonymous], 1979, SNAKE VENOMS
[2]  
BOWMAN WC, 1986, HDB EXPT PHARM, V79, P141
[3]  
CHANG C C, 1985, Proceedings of the National Science Council Republic of China Part B Life Sciences, V9, P126
[4]  
CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241
[5]  
Chang C. C., 1955, Journal of the Formosan Medical Association, V54, P103
[6]  
CHANG C. C., 1960, JOUR FORMOSAN MED ASSOC, V59, P315
[7]   SELECTIVE ANTAGONISM TO SUCCINYLCHOLINE-INDUCED DEPOLARIZATION BY ALPHA-BUNGAROTOXIN WITH RESPECT TO THE MODE OF ACTION OF DEPOLARIZING AGENTS [J].
CHANG, CC ;
CHIOU, LC ;
HWANG, LL .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (04) :1413-1419
[8]   REVERSALS OF THE NEOSTIGMINE-INDUCED TETANIC FADE AND ENDPLATE POTENTIAL RUN-DOWN WITH RESPECT TO THE AUTO-REGULATION OF TRANSMITTER RELEASE [J].
CHANG, CC ;
CHEN, SM ;
HONG, SJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1255-1261
[9]   A REGENERATING RELEASE OF ACETYLCHOLINE FROM MOUSE MOTOR-NERVE TERMINALS TREATED WITH ANTICHOLINESTERASE AGENTS [J].
CHANG, CC ;
HONG, SJ .
NEUROSCIENCE LETTERS, 1986, 69 (02) :203-207
[10]   N,O-DI AND N,N,O-TRI [H-3] ACETYL ALPHA-BUNGAROTOXINS AS SPECIFIC LABELING AGENTS OF CHOLINERGIC RECEPTORS [J].
CHANG, CC ;
CHEN, TF ;
CHUANG, ST .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (01) :147-160